Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
BV6 for Reliable Cell-Death Assays
2026-09-30
A scenario-based guide to using BV6 (SKU B4653) as an IAP antagonist in apoptosis, cytotoxicity, radiosensitization, and disease-model workflows. It connects mechanism, solvent handling, dose interpretation, and vendor-selection criteria to more defensible laboratory data.
-
Farnesylation, KRAS Condensates, and Translation
2026-09-30
A mechanistic and translational perspective on how farnesylation-driven KRAS phase separation may reshape biomarker strategy, combination therapy, and chemical-biology workflows in colon cancer.
-
Aligned Silk Fibroin–Ce6 Films for Infected Wounds
2026-09-29
The reference study developed an aligned silk fibroin film containing conjugated Chlorin e6 (Ce6) nanofibers, combining directional cell guidance with near-infrared photodynamic antibacterial activity. In an S. aureus wound model, the composite generated reactive oxygen species rapidly, reduced infection, and supported later-stage M2 macrophage polarization, illustrating how scaffold architecture and photochemistry can be integrated for wound repair.
-
HyperPFU high-fidelity DNA polymerase for mRNA PCR
2026-09-29
Build cleaner, more accurate DNA templates for in vitro transcription, especially when long or GC-rich cassettes challenge routine PCR. HyperPFU™ combines proofreading fidelity, processivity, blunt-end generation, and inhibitor tolerance for mRNA research workflows that connect template preparation to downstream QC, LNP formulation, and cell transfection.
-
Protein A/G Magnetic Co-IP/IP Kit Guide
2026-09-28
The Protein A/G Magnetic Co-IP/IP Kit uses recombinant Protein A/G magnetic beads for Fc region antibody binding, protein complex isolation, and downstream SDS-PAGE or mass spectrometry. Its magnetic workflow supports reproducible co-immunoprecipitation of protein complexes, but interaction claims require appropriate controls and orthogonal validation.
-
Angiotensin (1-7): Mechanism and Research Evidence
2026-09-28
Angiotensin (1-7) is an endogenous heptapeptide that signals primarily through the Mas receptor and is studied for counter-regulatory effects on angiotensin II pathways. The sequence Asp-Arg-Val-Tyr-Ile-His-Pro links product identity to research on signaling, tissue responses, and an emerging in-vitro spike-protein binding observation.
-
ASB5 Marks Muscle Satellite Cells but Is Dispensable
2026-09-27
Single-cell transcriptomic analyses identify ASB5 as a prominent marker of muscle satellite cells and their progeny, while a germline knockout shows that ASB5 is not required for normal muscle growth or acute injury repair under the conditions tested. The study distinguishes marker expression from functional necessity and offers a useful model for evaluating candidate stem-cell markers with both expression data and loss-of-function experiments.
-
Hematoxylin B3671: Practical Nuclear Staining Guide
2026-09-26
Hematoxylin B3671 is a solid nuclear stain for researchers preparing histological or cytological samples, including established hematoxylin and eosin workflows. It is a research reagent—not a complete staining kit—and is not intended for diagnostic, clinical, or medical use.
-
Stat3 Connects Fyn to Dopaminergic Neurodegeneration
2026-09-25
A neural-specific zebrafish model shows that constitutively active Fyn is associated with dopaminergic neuron loss, mitochondrial aggregation, and microglial inflammatory activation. Transcriptomic and chemical-inhibition results identify Stat3 as a downstream contributor that acts alongside NF-κB, offering a framework for studying kinase-driven neurodegeneration without implying that the two pathways are interchangeable.
-
From SAHH to m6A: A Fibrosis Research Roadmap
2026-09-25
A translational framework for using 3-Deazaadenosine hydrochloride to probe methyl-metabolism dependencies in hepatic stellate cells—while separating established m6A findings from testable SAHH hypotheses.
-
KRAS Condensates: Farnesylation as a Control Point
2026-09-24
A recent study connects KRAS farnesylation to condensate formation, protein processing, and colon tumor growth. For translational teams, the opportunity is to test this regulatory layer carefully—without confusing a promising mechanism with a validated clinical strategy or assuming an incompletely specified reagent has a particular function.
-
Hyperthermia and Cisplatin Drive Caspase-8-Linked Death
2026-09-24
A 2024 study reports that hyperthermia combined with cisplatin promotes K63-linked ubiquitination and accumulation of caspase-8, accompanying increased apoptosis and pyroptosis in cancer cells. The findings connect caspase-8 regulation with multiple cell-death outputs and suggest a mechanistic basis for studying treatment combinations, while leaving questions about model-specific transferability and pathway causality.
-
Calcitriol: VDR Biology, Evidence, and Research Use
2026-09-23
Calcitriol, also called 1,25-dihydroxy vitamin D3, is an active vitamin D metabolite used to investigate vitamin D receptor signaling and cellular biology. Evidence includes VDR-dependent decidualization findings in human endometrial stromal cells, while immune and cancer findings remain model-specific and should not be treated as clinical outcomes.
-
WZ4003 Lowers Tau Ser356 in Brain Tissue
2026-09-23
Taylor et al. associated tau phosphorylation at Ser356 with Alzheimer’s disease progression and neurofibrillary tangles, then tested the NUAK1/2 inhibitor WZ4003 in mouse and human brain slice cultures. The study found a culture- and species-dependent response, including selective reduction of p-tau Ser356 in live human tissue, while highlighting important limitations for translating ex vivo findings.
-
ATRNL1 and Cell States in Atrial Fibrillation
2026-09-22
This reference study applies large-scale single-nucleus RNA sequencing to human left atrial tissue and identifies cardiomyocyte- and macrophage-specific transcriptional changes associated with atrial fibrillation. ATRNL1 emerged as an AF-associated cardiomyocyte gene, with functional experiments linking its abundance to cellular stress responses and cardiac action-potential regulation.